22 PNP personnel in Olongapo City test positive for COVID-19 | Inquirer News

22 PNP personnel in Olongapo City test positive for COVID-19

OLONGAPO CITY –– The recent mass swab testing among the Philippine National Police (PNP) personnel in this city confirmed that at least 22 of them were infected with COVID-19, local health data showed.

This was the highest single-day record of COVID-19 infections among police personnel in the city since the pandemic began last year.

Most of them contracted the virus while on duty.

Article continues after this advertisement

But the local police office said all of its stations in the city would remain operational despite this.

FEATURED STORIES

The infected persons were placed in a quarantine facility for treatment and observation.

So far, the entire police workforce in Central Luzon has logged over 1,400 COVID-19 cases among their ranks. At least 180 of these remained active.

Article continues after this advertisement

Five PNP personnel in the region had also died of COVID-19 to date. INQ

LZB

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Health, Olongapo City, Philippine National Police, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.